日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Use of the Urine-to-Plasma Urea Ratio to Predict ADPKD Progression

利用尿液与血浆尿素比值预测ADPKD进展

Heida, Judith E; Gansevoort, Ron T; Messchendorp, A Lianne; Meijer, Esther; Casteleijn, Niek F; Boertien, Wendy E; Zittema, Debbie

Urinary Biomarkers to Identify Autosomal Dominant Polycystic Kidney Disease Patients With a High Likelihood of Disease Progression.

尿液生物标志物用于识别具有高疾病进展可能性的常染色体显性多囊肾病患者

Messchendorp A Lianne, Meijer Esther, Boertien Wendy E, Engels Gerwin E, Casteleijn Niek F, Spithoven Edwin M, Losekoot Monique, Burgerhof Johannes G M, Peters Dorien J M, Gansevoort Ron T

Urinary EGF Receptor Ligand Excretion in Patients with Autosomal Dominant Polycystic Kidney Disease and Response to Tolvaptan.

常染色体显性多囊肾病患者尿液中 EGF 受体配体排泄及对托伐普坦的反应

Harskamp Laura R, Gansevoort Ron T, Boertien Wendy E, van Oeveren Wim, Engels Gerwin E, van Goor Harry, Meijer Esther

Kidney function and plasma copeptin levels in healthy kidney donors and autosomal dominant polycystic kidney disease patients

健康肾脏捐献者和常染色体显性多囊肾病患者的肾功能和血浆血管加压素原水平

Zittema, Debbie; van den Berg, Else; Meijer, Esther; Boertien, Wendy E; Muller Kobold, Anneke C; Franssen, Casper F M; de Jong, Paul E; Bakker, Stephan J L; Navis, Gerjan; Gansevoort, Ron T

Relationship of copeptin, a surrogate marker for arginine vasopressin, with change in total kidney volume and GFR decline in autosomal dominant polycystic kidney disease: results from the CRISP cohort

血管加压素替代标志物血管加压素原与常染色体显性多囊肾病患者肾脏总体积变化和肾小球滤过率下降的关系:来自 CRISP 队列研究的结果

Boertien, Wendy E; Meijer, Esther; Li, Jie; Bost, James E; Struck, Joachim; Flessner, Michael F; Gansevoort, Ron T; Torres, Vicente E